71.55 USD
↗ 1.80 (2.58%)AT CLOSE (03:59 PM EDT)
10x Genomics, Inc. Class A Common Stock
TXGNASDAQ • USD
71.37
↘ 0.18 (0.25%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
71.37
↘ 0.18 (0.25%)
Market: CLOSED
TXG is currently priced at $71.55. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 23, 2026.
Open?$68.94
High?$71.83
Low?$67.52
Prev. Close?$69.75
Volume?2.2M
Avg. Volume?3.9M
VWAP?$70.98
Rel. Volume?0.57x
Bid / Ask
Bid?$71.11 × 100
Ask?$71.70 × 200
Spread?$0.59
Midpoint?$71.41
Valuation & Ratios
Market Cap?9.3B
Shares Out?120.2M
Float?116.9M
Float %?97.3%
P/E Ratio?N/A
P/B Ratio?11.29
EPS?-$0.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Employees
1.2K
Market Cap
9.3B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
Listed
2019-09-12
Address
6230 STONERIDGE MALL ROAD
PLEASANTON, CA 94588
Phone: (925) 401-7300
PLEASANTON, CA 94588
Phone: (925) 401-7300
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?65
Short Sent.?65
Piotroski F-Score?1/9Weak
Altman Z-Score?26.22Safe
Confidence?55%Low
Short InterestHigh
Short % of Float?13.15%High
Short Interest?15.4M
Days to Cover?4.5
Free Float116.9M
Avg Daily Volume3.4M
Settlement Date2026-09-30
Financial Health
Current Ratio?5.69Strong
Quick Ratio?5.25Strong
Cash Ratio?4.24Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score47/100
P/E?N/A▾
P/B?11.29HIGH▾
Peers100
S&P17
P/S?15.11HIGH▾
Peers67
S&P3
P/FCF?76.8PRICEY▾
S&P3
EV/EBITDA?-170.3CHEAP▾
S&P97
EV/Sales?14.30HIGH▾
Peers67
S&P3
Returns & Efficiency
ROE?-9.1%WEAK▾
Peers50
S&P9
ROA?-7.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$121.4M
Enterprise Value?$8.8B
Fundamentals ratios updated end of day